A review-style paper proposing that dysregulated gut ecology and gut–brain interactions may play a role in Parkinson’s disease and could inform therapeutic or biomarker strategies.

Highlights the gut–brain axis and microbiome as promising, translational targets for PD diagnostics and interventions, but absence of an abstract and likely review nature limit immediate actionable insights.